Table 1.
Actual Episode Expenditures | |||||||
---|---|---|---|---|---|---|---|
N | Minimum | 1st quartile | Median | Mean | 3rd quartile | Maximum | |
Sex | |||||||
Female | 2923 | 461.09 | 2272.80 | 5278.11 | 13,879.26 | 18,920.21 | 71,185.40 |
Male | 15 | 1676.08 | 3378.14 | 5310.87 | 14,962.33 | 22,495.87 | 60,645.54 |
Chemotherapy drugs | |||||||
Part B | 828 | 1486.41 | 17,582.50 | 30,595.09 | 33,026.14 | 48,364.65 | 71,185.40 |
Part D | 2110 | 461.09 | 1766.81 | 3270.07 | 6373.39 | 6440.57 | 71,185.40 |
Surgery | |||||||
No | 2818 | 461.09 | 2214.97 | 4949.55 | 13,449.74 | 18,088.10 | 71,185.40 |
Yes | 120 | 1364.95 | 9037.30 | 17,372.43 | 24,101.19 | 35,220.38 | 71,185.40 |
Insurance | |||||||
No PartDa | 127 | 1111.65 | 14,545.65 | 24,983.93 | 28,798.25 | 42,946.34 | 71,185.40 |
PartD LISb | 130 | 461.09 | 1989.09 | 4872.79 | 15,087.51 | 20,435.59 | 71,185.40 |
PartD NoLISc | 1794 | 461.09 | 1888.15 | 3828.62 | 11,102.19 | 12,297.31 | 71,185.40 |
Full duald | 887 | 461.09 | 3625.93 | 7926.81 | 17,201.15 | 24,179.71 | 71,185.40 |
Radiation | |||||||
No | 2681 | 461.09 | 2154.71 | 4596.04 | 12,460.25 | 15,144.30 | 71,185.40 |
Yes | 257 | 1393.47 | 12,220.82 | 25,329.08 | 28,745.46 | 42,778.24 | 71,185.40 |
Trial participation | |||||||
No | 2923 | 461.09 | 2271.26 | 5260.65 | 13,869.41 | 18,975.22 | 71,185.40 |
Yes | 15 | 2273.81 | 6065.91 | 16,671.52 | 16,880.54 | 18,742.96 | 48,306.45 |
Comorbidities | |||||||
0 | 828 | 461.09 | 1639.29 | 3450.09 | 11,750.76 | 14,716.46 | 71,185.40 |
1 | 727 | 461.09 | 2179.77 | 5079.50 | 12,080.17 | 14,285.17 | 71,185.40 |
2 | 469 | 461.09 | 2872.91 | 5500.16 | 14,587.20 | 20,551.60 | 71,185.40 |
3 | 288 | 461.09 | 2973.28 | 7702.07 | 16,603.32 | 24,587.09 | 71,185.40 |
≥ 4 | 271 | 469.21 | 5298.04 | 13,266.07 | 19,067.06 | 27,077.94 | 71,185.40 |
New enrollee | 355 | 461.09 | 2026.10 | 5079.58 | 15,468.37 | 25,367.09 | 71,185.40 |
Chemotherapy clean period | |||||||
62–730 days | 1235 | 461.09 | 1677.36 | 3147.19 | 6540.55 | 6463.20 | 71,185.40 |
> 731 days | 657 | 461.09 | 2688.89 | 8603.03 | 16,839.45 | 25,329.08 | 71,185.40 |
1–61 days | 1046 | 461.09 | 3957.41 | 12,421.50 | 20,700.20 | 33,603.99 | 71,185.40 |
Institutional status | |||||||
Yes | 14 | 3515.99 | 7298.26 | 14,258.97 | 22,597.47 | 34,961.03 | 66,192.20 |
No | 2924 | 461.09 | 2271.99 | 5260.37 | 13,843.07 | 18,831.37 | 71,185.40 |
Note: aNo PartD means no part D enrollment; bPartD LIS means does not have full Medicaid benefits but does have Part D with low income subsidy; cPartD NoLIS means has Part D enrollment but no low income subsidy; dFull dual means full Medicaid benefits (including Part D and LIS). eAge and HRR relative cost are continuous variables and not included in this table; scatterplots of episode costs versus age and HRR relative cost are shown in Fig. 2